Home » Market Spotlight » Magenta Lifecare IPO: Must-know updates on this investment opportunity

Magenta Lifecare IPO: Must-know updates on this investment opportunity

Investors are flocking to this BSE SME IPO. With 474 times retail and 413 times NII subscriptions, find out why this offering is so attractive!

The Indian mattress industry is highly fragmented, with numerous branded and non-branded players selling various types of mattresses through local distribution channels. 

Dominated by the unorganised sector, the organised segment is now growing due to rising consumer demand for quality products. Tech advancements and shifting client dynamics are driving this expansion.

Magenta Lifecare Pvt Ltd operates in this evolving market, providing a range of foam-based mattresses and pillows. Established in 2015, Magenta has carved out a niche with its focus on quality and innovation.

Now, Magenta is going public with a BSE SME IPO. In this blog, let’s explore the key details of the Magenta Lifecare IPO and what it means for investors.

You may also like: What sets an SME IPO apart from a regular IPO?

Magenta Lifecare Private Limited

Magenta Lifecare Pvt Ltd, is known for its wide range of foam-based products. The company operates under the brand name “Magenta” in India. It manufactures various types of mattresses and pillows, catering to different customer needs.

The product range consists of pocketed spring, latex-based, bonded, and memory foam mattresses. They also sell contour foam pillows, memory foam pillows, and moulded memory foam pillows. The purpose of these goods is to improve the quality of sleep by offering comfort and support.

The company prioritises innovation, launching innovative goods including herbal mattresses made of bamboo charcoal and green tea. Additionally, they sell adjustable bed frames, processed raw foam, and pet bed mattresses. The company aims to deliver quality products to a diverse customer base, from retail to hotels and institutions.

Also read: Economics of the tourism and hospitality industry in India

Magenta Lifecare Pvt Ltd today

The Gujarat-based manufacturing plant of Magenta Lifecare is capable of making 70,000 pillows and 60,000 mattresses per year. The key raw materials include various types of foam, fabric, adhesive, cotton, and threads, all sourced domestically. For the financial year 2023, raw material purchases represented 57.98% of the revenue from operations.

Magenta Lifecare Pvt Ltd Vadodara reported a diverse revenue mix. Mattresses contributed 36.81% of the total revenue. Pillows accounted for 58.11%. Raw foam and hydraulic beds made up 1.09% and 1.82% respectively. Additional products made up 2.17%.

By online as well as offline platforms, the company sells its merchandise. Offline sales include multi-brand outlets and a network of dealers. Online sales are conducted through e-commerce platforms. However, as of December 2023 offline sales dominate, comprising 99.92% of total revenue, while online sales are just 0.15%.

In terms of geography, the company has an extensive distributor and dealer network across multiple states in India. A significant portion, 68.16%, of the revenue comes from Gujarat. 

Here, is table summarises the pre-issue shareholding pattern, dividing it among promoters, the promoter group, and the public.

ParticularsPercentage (%) holding pre-issue
Promoters and promoter group
Divyesh Modi44.93%
Khyati Modi34.19%
Vipinchandra Modi5.54%
Priyang Patel3.92%
Jimit Gandhi2.24%
Jagdish Patel1.13%
Riyaz Shaikh0.01%
Urvi Vyas0.01%
Nilesh Pravinkmar Verma0.01%
7NR Retail Limited8.62%

Source: Magenta Lifecare RHP

Also read: Exploring Gujarat Gas Ltd. (GGL)

Financial snapshot

(₹ lakh)FY23FY22FY21
Revenue from operations906.61924.4964.74
Growth in revenue from operations-1.92%-4.18%NA
EBITDA margin9.62%11.50%10.83%
Restated profit after tax24.5518.8919.44
PAT margin2.71%2.04%2.02%
Net worth520.81361.73142.85
Capital employed973.811,119.241,125.56
Return on capital employed- ROCE%11.86%8.95%7.64%
Return on equity- ROE%5.56%7.49%14.60%

Source: Magenta Lifecare RHP

Magenta Lifecare IPO details

Key facts and figures

Fresh issue₹7 crore
Total issue size₹7 crore
Price band₹35
Lot size4000
Stock exchangeBSE SME

Source: Magenta Lifecare RHP

In the Magenta Lifecare IPO, which is estimated to be worth ₹7 crore, 2,000,000 new equity shares with a face value of ₹10 apiece would be issued. There is no offer-for-sale component to this issue.

The BSE SME exchange will list this initial public offering. The issue’s lead manager is Fedex Securities, while the registrar is Cameo Corporate Services. The market maker is Sunflower Broking.

A minimum of ₹1.4 lakh must be invested by retail investors. HNIs, or high net worth individuals, must apply for a minimum of two lots, or 8,000 shares, with an investment of ₹2.8 lakh.

IPO calendar

Subscription period5th June to 7th June 2024
Allotment finalisation date10th June 2024
Refund initiation date11th June 2024
Share credit date11th June 2024
Listing date12th June 2024
Anchor investors lock-in release date (50%)10th July 2024
Anchor investors lock-in release date (remaining 50%)10th September 2024

The above schedule is subject to change. The anchor lock-in period expires thirty days after the actual allotment date for fifty percent of the shares and ninety days thereafter for the other fifty percent. By June 11, 2024, the allotment status will be available on both the exchange’s and company’s websites.

Fund utilisation plan

Magenta Lifecare intends to utilise the funds from the IPO for specific purposes. Supporting the company’s increasing working capital requirements is the main goal. The total amount allotted is ₹4.24 crore. A portion of the money will also be utilised for basic business needs. The amount allotted is ₹1.74 crore. 

Subscription status for Magenta Lifecare IPO

On day 1, the Magenta Lifecare IPO was subscribed 24.49 times, indicating strong initial interest. By day 2, this interest had surged, with the subscription status reaching 120.75 times.

The IPO has received 450.76 subscriptions as of day three. The retail segment had 474.34 subscriptions, indicating a high level of involvement from private investors. There was significant interest from larger investors as evidenced by the 413.81 subscriptions made to the Non-Institutional Investor (NII) component.

Latest GMP of Magenta Lifecare Pvt Ltd 

The recently released grey market premium (GMP) for the Magenta Lifecare IPO is +₹28 as of June 7, 2024. The anticipated listing price for the company’s shares is ₹63 per share, given the higher end of the IPO pricing band and the current GMP. This is 80% more than the ₹35 IPO price.

GMP is an indicator of investors’ readiness to pay more than the issue price. It shows that the market is feeling upbeat before the official listing.


The Magenta Lifecare IPO presents an interesting opportunity for investors, given its strong market demand and positive grey market premium. But comes with notable risks. Failure to keep up with consumer trends and technological advancements could impact demand and operations. Investors should consider these factors before making a decision.

Enjoyed reading this? Share it with your friends.

Post navigation

Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *